Article
Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Feb 2013
Hussain Shehnaz K, Zhu Weiming, Chang Shen-Chih, Breen Elizabeth Crabb, Vendrame Elena, Magpantay Larry, Widney Dan, Conn Daniel, Sehl Mary, Jacobson Lisa P, Bream Jay H, Wolinsky Steven, Rinaldo Charles R, Ambinder Richard F, Detels Roger, Zhang Zuo-Feng, Martínez-Maza Otoniel
Abstract excerpt
BACKGROUND: CXCL13 and CXCR5 are a chemokine and receptor pair whose interaction is critical for naïve B-cell trafficking and activation within germinal centers. We sought to determine whether CXCL13 levels are elevated before HIV-associated non-Hodgkin B-cell lymphoma (AIDS-NHL), and whether polymorphisms in CXCL13 or CXCR5 are associated with AIDS-NHL risk and CXCL13 levels in a large cohort of HIV-infected...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.